Its catalytic repertoire expanded by modification and in-vitro-selection of nucleicacid libraries endows ribozymes a great potential as gene therapeutic agents and nucleicacidprobes.
The present invention further provides nucleicacid molecules for use as molecular probes, or as primers for polymerase chain reaction (PCR) amplification, i. e. synthetic or natural oligonucleotides.